page_banner

Ngathi

Imbuyekezo Hangzhou Copel Chemical Co., Ltd.

IHangzhou Copel Chemical Co., Ltd. ibekwe kwisixeko esihle, iSixeko saseHangzhou. I-Hangzhou Copel Chemical Co., Ltd. (emva koku ibizwa ngokuba yi "Copel") ngumnikezeli ngobuchule kwii-API, abenzi bamayeza, izinto ezincedisayo kunye nezongezo zokutya kunye neZilwanyana e-China. Okwangoku, ngeli xesha sigxininisa ukuba somelele kakhulu kwimveliso yesivumelwano.
ICopel iphuhlise intsebenziswano ezinzileyo kunye nabenzi abaninzi abalungileyo eTshayina. Ngokukodwa sinemithombo elungileyo yesivumelwano.
ICopel ithumele iintlobo ngeentlobo zeemveliso kwiimarike ezahlukeneyo. Iimveliso zethu kunye nenkonzo yobungcali yanelisekile kakhulu ngabathengi.

Umgangatho wokuqala

Ityala kuqala

Intsebenziswano ye-Win-Win

Ngomhla wesi-2 ku-Matshi, i-US FDA ivume isicelo esitsha seziyobisi (i-NDA) se-AZSTARYS (igama lekhowudi: KP415), kanye ngemini, kunyango lwengxaki yokusilela kokuphazamiseka kwengqondo (ADHD) kwizigulana ezineminyaka emi-6 nangaphezulu. Iya kuthengiswa eMelika. Ukuya
I-AZSTARYS yifom yedosi ye-capsule yefomathi eyenziwe nge-dexmethylphenidate (d-MPH) yeprodrug serdexmethylphenidate (SDX) kunye nokukhululwa kwangoko d-MPH. I-AZSTARYS iqulethe i-30% yokukhululwa kwangoko kwe-d-MPH kunye ne-70% eyandisiweyo yokukhupha i-SDX entsha. Emva kokufunxwa kwiphecana lesisu, i-SDX iguqulwe yenziwa i-d-MPH, kwaye i-d-MPH ikhutshwa kancinci kungaphelanga usuku.
Xa kuthelekiswa neziyobisi ezithengiswayo ngoku i-Vyvanse (Ridexamphetamine Dimesylate Capsules) kunye ne-Osmotic (Methylphenidate Hydrochloride Sustained Release Tablets), i-AZSTARYS inethuba lokuqala kwangoko ngenxa yokukhutshwa kwangoko kwe-d-MPH. Xa kuthelekiswa ne-Adderall XR (i-amphetamine complex salt-release-release capsules) kunye ne-Focalin XR (dexmethylphenidate hydrochloride-release-release capsules), kuba i-SDX yiprodrug, inokunciphisa ukuxhomekeka kwiziyobisi.